Breast Cancer Clinical Trials in Brussels
12 recruitingBrussels, Belgium
Showing 1–12 of 12 trials
Recruiting
Phase 2
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
Breast Cancer
Hoffmann-La Roche80 enrolled14 locationsNCT07368998
Recruiting
Phase 3
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Breast Cancer
Stemline Therapeutics, Inc.4,220 enrolled524 locationsNCT06492616
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Breast CancerLiver CancerEsophageal Cancer+35 more
UMC Utrecht8,000 enrolled18 locationsNCT04075305
Recruiting
Phase 3
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
Breast Cancer
Daiichi Sankyo250 enrolled86 locationsNCT05950945
Recruiting
Phase 3
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Breast Cancer
Celcuity Inc674 enrolled203 locationsNCT06757634
Recruiting
Phase 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Breast CancerEsophageal CancerGastric Cancer+11 more
Daiichi Sankyo740 enrolled84 locationsNCT06172478
Recruiting
Phase 2
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
Breast Cancer
BicycleTx Limited66 enrolled39 locationsNCT06840483
Recruiting
Not Applicable
WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer
Breast Cancer
Université Catholique de Louvain20 enrolled2 locationsNCT07142096
Recruiting
Not Applicable
OligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
Breast CancerProstate CancerNSCLC
European Organisation for Research and Treatment of Cancer - EORTC302 enrolled15 locationsNCT06462963
Recruiting
Not Applicable
ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study
Breast Cancer
Jules Bordet Institute250 enrolled1 locationNCT06227338
Recruiting
A Study of the Gut Microbiome in Hormone Receptor-positive HER2-negative Breast Cancer Treated With CDK4/6 Inhibitors
Breast Cancer
Cliniques universitaires Saint-Luc- Université Catholique de Louvain100 enrolled3 locationsNCT06171360
Recruiting
Not Applicable
Multidisciplinary Approach to Fatigue
Breast CancerGerm Cell Tumor
Jules Bordet Institute50 enrolled1 locationNCT05502224